 MENLO PARK, Calif., Feb. 10, 2021 GLOBE NEWSWIRE -- Pacific Biosciences of California, Inc. NASDAQ: PACB the Company, a leading provider of high-quality, long-read sequencing platforms, today announced that SB Management, a subsidiary of Softbank Group Corp., will make an investment of 900 million in convertible senior notes to support the Companys future growth initiatives. 